Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin

被引:14
|
作者
Monzen, Hajime
Hara, Masatake
Hirata, Makoto
Nakanishi, Akira
Ogasawara, Makoto
Suzuki, Takatoshi
Sato, Tamie
Shimoyama, Hisashi
Tadehara, Futoshi
Hirose, Kunihiko
Yuki, Rumio
机构
[1] Otsu Red Cross Hosp, Dept Radiol, Otsu, Shiga 5208511, Japan
[2] Otsu Red Cross Hosp, Dept Cardiol, Otsu, Shiga 5208511, Japan
关键词
single-photon emission tomography; technetium-99m sestamibi; technetium-99m tetrofosmin; body position; scattered rays;
D O I
10.1007/BF02984684
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have devised a new position (Monzen position) which can suppress the influence of scattered rays from surrounding organs (liver, etc.) when conducting myocardial imaging. Unlike the conventional techniques, which require a waiting period of 30-60 minutes before imaging can be started after the infusion of technetium-99m sestamibi or technetium-99m tetrofosmin, this position allows single-photon emission tomography to be started about 5-10 minutes after the infusion of the tracer. Therefore, with this technique the total time required for imaging is reduced and consequently the physical and mental burden of the patient is also reduced. Furthermore, the number of patients who can receive this test at any facility can be increased. This position may also be applicable in myocardial scintigraphy using some other tracers.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 50 条
  • [41] Evaluation of radiochemical purity of technetium-99m mertiatide and technetium-99m tetrofosmin stored at 30 degrees Celsius during the shelf-life.
    Pitman, Stephanie
    Hartman, Neil
    Soanes, Russell
    PHARMACOTHERAPY, 2017, 37 (06): : E52 - E53
  • [42] The Electrocardiograms Change of Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Chinese Population
    Xie, B. Q.
    Tian, Y. Q.
    Zhang, X. L.
    Shen, R.
    Fang, W.
    Yang, M. F.
    He, Z. X.
    CARDIOLOGY, 2009, 114 : 104 - 104
  • [43] The effect of barium sulfate on subdiaphragmatic activity in technetium-99m sestamibi myocardial perfusion scan
    Hekmati, Pooya
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 158 - 159
  • [44] Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis
    Yuji Hiromatsu
    Masatoshi Ishibashi
    Ikuyo Miyake
    Kyohei Nonaka
    European Journal of Nuclear Medicine, 1998, 25 : 1448 - 1452
  • [45] Scintimammography with technetium-99m tetrofosmin in suspected breast cancer
    Schillaci, O
    Scopinaro, F
    Danieli, R
    Picardi, V
    Tavolaro, R
    Cannas, P
    Colella, AC
    ANTICANCER RESEARCH, 1997, 17 (3B) : 1623 - 1626
  • [46] Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia
    McGoron, AJ
    Gerson, MC
    Biniakiewicz, DS
    Roszell, NJ
    Washburn, LC
    Millard, RW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (12) : 1479 - 1486
  • [47] Intense uptake of technetium-99m tetrofosmin by lactating breasts
    Yamamoto, W
    Shuke, N
    Usui, K
    Aburano, T
    Takehara, N
    Kikuchi, K
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (01) : 76 - 77
  • [48] Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis
    Hiromatsu, Y
    Ishibashi, M
    Miyake, I
    Nonaka, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (10) : 1448 - 1452
  • [49] Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy
    Morishita, S
    Kondo, Y
    Nomura, M
    Miyajima, H
    Nada, T
    Ito, S
    Nakaya, Y
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06): : 743 - 747
  • [50] Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia
    Anthony J. McGoron
    Myron C. Gerson
    Danuta S. Biniakiewicz
    Nancy J. Roszell
    Lee C. Washburn
    Ronald W. Millard
    European Journal of Nuclear Medicine, 1997, 24 : 1479 - 1486